Abstract
ARMC5 mutations have recently been identified as a common genetic cause of primary bilateral macronodular adrenal hyperplasia (PBMAH). We aimed to assess the prevalence of ARMC5 germline mutations and correlate genotype with phenotype in a large cohort of PBMAH patients. A multicenter study was performed, collecting patients from different endocrinology units in Italy. Seventy-one PBMAH patients were screened for small mutations and large rearrangements in the ARMC5 gene: 53 were cortisol-secreting (two with a family history of adrenal hyperplasia) and 18 were non-secreting cases of PBMAH. Non-mutated and mutated patients’ clinical phenotypes were compared and related to the type of mutation. A likely causative germline ARMC5 mutation was only identified in cortisol-secreting PBMAH patients (one with a family history of adrenal hyperplasia and ten apparently sporadic cases). Screening in eight first-degree relatives of three index cases revealed four carriers of an ARMC5 mutation. Evidence of a second hit at somatic level was identified in five nodules. Mutated patients had higher cortisol levels (p = 0.062), and more severe hypertension and diabetes (p < 0.05). Adrenal glands were significantly larger, with a multinodular phenotype, in the mutant group (p < 0.01). No correlation emerged between type of mutation and clinical parameters. ARMC5 mutations are frequent in cortisol-secreting PBMAH and seem to be associated with a particular pattern of the adrenal masses. Their identification may have implications for the clinical care of PBMAH cases and their relatives.
Similar content being viewed by others
References
A. Lacroix, ACTH-independent macronodular adrenal hyperplasia. Best Pract. Res. Clin. Endocrinol. Metab. 23, 245–259 (2009)
E. Louiset, C. Duparc, J. Young, S. Renouf, M. Tetsi Nomigni, I. Boutelet, R. Libe, Z. Bram, L. Groussin, P. Caron, A. Tabarin, F. Grunenberger, S. Christin-Maitre, X. Bertagna, J.M. Kuhn, Y. Anouar, J. Bertherat, H. Lefebvre, Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia. N. Engl. J. Med. 369, 2115–2125 (2013)
N.M. Albiger, G. Occhi, B. Mariniello, M. Iacobone, G. Favia, A. Fassina, D. Faggian, F. Mantero, C. Scaroni, Food-dependent Cushing’s syndrome: from molecular characterization to therapeutical results. Eur. J. Endocrinol. 157, 771–778 (2007)
N. El Ghorayeb, I. Bourdeau, A. Lacroix, Multiple aberrant hormone receptors in Cushing’s syndrome. Eur. J. Endocrinol. 173, M45–M60 (2015)
A. Horvath, S. Boikos, C. Giatzakis, A. Robinson-White, L. Groussin, K.J. Griffin, E. Stein, E. Levine, G. Delimpasi, H.P. Hsiao, M. Keil, S. Heyerdahl, L. Matyakhina, R. Libe, A. Fratticci, L.S. Kirschner, K. Cramer, R.C. Gaillard, X. Bertagna, J.A. Carney, J. Bertherat, I. Bossis, C.A. Stratakis, A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat. Genet. 38, 794–800 (2006)
D. Vezzosi, R. Libe, C. Baudry, M. Rizk-Rabin, A. Horvath, I. Levy, F. Rene-Corail, B. Ragazzon, C.A. Stratakis, G. Vandecasteele, J. Bertherat, Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors. J. Clin. Endocrinol. Metab. 97, E2063–E2069 (2012)
A. Rothenbuhler, A. Horvath, R. Libe, F.R. Faucz, A. Fratticci, M.L. Raffin Sanson, D. Vezzosi, M. Azevedo, I. Levy, M.Q. Almeida, M. Lodish, M. Nesterova, J. Bertherat, C.A. Stratakis, Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours. Clin. Endocrinol. (Oxf.) 77, 195–199 (2012)
G. Di Dalmazi, C. Kisker, D. Calebiro, M. Mannelli, L. Canu, G. Arnaldi, M. Quinkler, N. Rayes, A. Tabarin, M. Laure Jullie, F. Mantero, B. Rubin, J. Waldmann, D.K. Bartsch, R. Pasquali, M. Lohse, B. Allolio, M. Fassnacht, F. Beuschlein, M. Reincke, Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing’s syndrome: a European multicentric study. J. Clin. Endocrinol. Metab. 99, E2093–E2100 (2014)
F. Beuschlein, M. Fassnacht, G. Assie, D. Calebiro, C.A. Stratakis, A. Osswald, C.L. Ronchi, T. Wieland, S. Sbiera, F.R. Faucz, K. Schaak, A. Schmittfull, T. Schwarzmayr, O. Barreau, D. Vezzosi, M. Rizk-Rabin, U. Zabel, E. Szarek, P. Salpea, A. Forlino, A. Vetro, O. Zuffardi, C. Kisker, S. Diener, T. Meitinger, M.J. Lohse, M. Reincke, J. Bertherat, T.M. Strom, B. Allolio, Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome. N. Engl. J. Med. 370, 1019–1028 (2014)
G. Assie, R. Libe, S. Espiard, M. Rizk-Rabin, A. Guimier, W. Luscap, O. Barreau, L. Lefevre, M. Sibony, L. Guignat, S. Rodriguez, K. Perlemoine, F. Rene-Corail, F. Letourneur, B. Trabulsi, A. Poussier, N. Chabbert-Buffet, F. Borson-Chazot, L. Groussin, X. Bertagna, C.A. Stratakis, B. Ragazzon, J. Bertherat, ARMC5 mutations in macronodular adrenal hyperplasia with Cushing’s syndrome. N. Engl. J. Med. 369, 2105–2114 (2013)
F.R. Faucz, M. Zilbermint, M.B. Lodish, E. Szarek, G. Trivellin, N. Sinaii, A. Berthon, R. Libe, G. Assie, S. Espiard, L. Drougat, B. Ragazzon, J. Bertherat, C.A. Stratakis, Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation. J. Clin. Endocrinol. Metab. 99, E1113–E1119 (2014)
G.A. Alencar, A.M. Lerario, M.Y. Nishi, B.M. Mariani, M.Q. Almeida, J. Tremblay, P. Hamet, I. Bourdeau, M.C. Zerbini, M.A. Pereira, G.C. Gomes, S. Rocha Mde, J.L. Chambo, A. Lacroix, B.B. Mendonca, M.C. Fragoso, ARMC5 mutations are a frequent cause of primary macronodular adrenal hyperplasia. J. Clin. Endocrinol. Metab. 99, E1501–E1509 (2014)
L. Gagliardi, A.W. Schreiber, C.N. Hahn, J. Feng, T. Cranston, H. Boon, C. Hotu, B.E. Oftedal, R. Cutfield, D.L. Adelson, W.J. Braund, R.D. Gordon, D.A. Rees, A.B. Grossman, D.J. Torpy, H.S. Scott, Armc5 mutations are common in familial bilateral macronodular adrenal hyperplasia. J. Clin. Endocrinol. Metab. (2014). doi:10.1210/jc.20141265
S. Espiard, L. Drougat, R. Libe, G. Assie, K. Perlemoine, L. Guignat, G. Barrande, F. Brucker-Davis, F. Doullay, S. Lopez, E. Sonnet, F. Torremocha, D. Pinsard, N. Chabbert-Buffet, M.L. Raffin-Sanson, L. Groussin, F. Borson-Chazot, J. Coste, X. Bertagna, C.A. Stratakis, F. Beuschlein, B. Ragazzon, J. Bertherat, armc5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences. J. Clin. Endocrinol. Metab. 100, E926–E935 (2015)
G. Occhi, M. Losa, N. Albiger, G. Trivellin, D. Regazzo, M. Scanarini, J.L. Monteserin-Garcia, B. Frohlich, S. Ferasin, M.R. Terreni, A. Fassina, L. Vitiello, G. Stalla, F. Mantero, C. Scaroni, The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells. J. Neuroendocrinol. 23, 641–649 (2011)
S.A. Bustin, V. Benes, J.A. Garson, J. Hellemans, J. Huggett, M. Kubista, R. Mueller, T. Nolan, M.W. Pfaffl, G.L. Shipley, J. Vandesompele, C.T. Wittwer, The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55, 611–622 (2009)
U. Elbelt, A. Trovato, M. Kloth, E. Gentz, R. Finke, J. Spranger, D. Galas, S. Weber, C. Wolf, K. Konig, W. Arlt, R. Buttner, P. May, B. Allolio, J.G. Schneider, Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma. J. Clin. Endocrinol. Metab. 100, E119–E128 (2015)
P. Mulatero, F. Schiavi, T.A. Williams, S. Monticone, G. Barbon, G. Opocher, F. Fallo: ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions. J. Hum. Hypertens. doi:10.1038/jhh.2015.98 (2015)
M. Zilbermint, P. Xekouki, F.R. Faucz, A. Berthon, A. Gkourogianni, M.H. Schernthaner-Reiter, M. Batsis, N. Sinaii, M.M. Quezado, M. Merino, A. Hodes, S.B. Abraham, R. Libe, G. Assie, S. Espiard, L. Drougat, B. Ragazzon, A. Davis, S.Y. Gebreab, R. Neff, E. Kebebew, J. Bertherat, M.B. Lodish, C.A. Stratakis, Primary aldosteronism and ARMC5 variants. J. Clin. Endocrinol. Metab. 100, E900–E909 (2015)
S. Suzuki, I. Tatsuno, E. Oohara, A. Nakayama, E. Komai, A. Shiga, T. Kono, T. Takiguchi, S. Higuchi, I. Sakuma, H. Nagano, N. Hashimoto, T. Mayama, H. Koide, H. Sasano, Y. Nakatani, T. Imamoto, T. Ichikawa, K. Yokote, T. Tanaka, Germline deletion of Armc5 in familial primary macronodular adrenal hyperplasia. Endocr. Pract. 21, 1152–1160 (2015)
M. Khajavi, K. Inoue, J.R. Lupski, Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur. J. Hum. Genet. 14, 1074–1081 (2006)
E.D. Austin, J.A. Phillips, J.D. Cogan, R. Hamid, C. Yu, K.C. Stanton, C.A. Phillips, L.A. Wheeler, I.M. Robbins, J.H. Newman, J.E. Loyd, Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension. Respir. Res. 10, 87 (2009). doi:10.1186/1465-9921-10-87
M. Morey, L. Castro-Feijoo, J. Barreiro, P. Cabanas, M. Pombo, M. Gil, I. Bernabeu, J.M. Diaz-Grande, L. Rey-Cordo, G. Ariceta, I. Rica, J. Nieto, R. Vilalta, L. Martorell, J. Vila-Cots, F. Aleixandre, A. Fontalba, L. Soriano-Guillen, J.M. Garcia-Sagredo, S. Garcia-Minaur, B. Rodriguez, S. Juaristi, C. Garcia-Pardos, A. Martinez-Peinado, J.M. Millan, A. Medeira, O. Moldovan, A. Fernandez, L. Loidi, Genetic diagnosis of X-linked dominant Hypophosphatemic Rickets in a cohort study: tubular reabsorption of phosphate. BMC Med. Genet. (2011). doi:10.1186/1471-2350-12-116
R. Correa, M. Zilbermint, A. Berthon, S. Espiard, M. Batsis, G.Z. Papadakis, P. Xekouki, M.B. Lodish, J. Bertherat, F.R. Faucz, C.A. Stratakis, The ARMC5 gene shows extensive genetic variance in primary macronodular adrenocortical hyperplasia. Eur. J. Endocrinol. 173, 435–440 (2015)
C.A. Stratakis, S.A. Boikos, Genetics of adrenal tumors associated with Cushing’s syndrome: a new classification for bilateral adrenocortical hyperplasias. Nat. Clin. Pract. Endocrinol. Metab. 3, 748–757 (2007)
N.M. Albiger, F. Ceccato, M. Zilio, M. Barbot, G. Occhi, S. Rizzati, A. Fassina, F. Mantero, M. Boscaro, M. Iacobone, C. Scaroni, An analysis of different therapeutic options in patients with Cushing’s syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experience. Clin. Endocrinol. (Oxf) 82, 808–815 (2015)
M. Iacobone, N. Albiger, C. Scaroni, F. Mantero, A. Fassina, G. Viel, M. Frego, G. Favia, The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH). World J. Surg. 32, 882–889 (2008)
Acknowledgments
The authors would like to thank the following people for all their help in patients’ collection and characterization during this study: Dr Laura Trementino, Dr Paola Sartorato, Dr Mattia Barbot, Dr Marialuisa Zilio, Dr Margherita Rizzato, and Prof Franco Mantero.
Funding
This work was funded by the Italian Ministry of University and Research (MIUR) through the FIRB project no. RBAP1153LS.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Additional information
N. M. Albiger, D. Regazzo, G. Occhi and C. Scaroni have equally contributed to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Albiger, N.M., Regazzo, D., Rubin, B. et al. A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype. Endocrine 55, 959–968 (2017). https://doi.org/10.1007/s12020-016-0956-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-016-0956-z